James E. Flynn

13F Holdings History for ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

Symbol: SPRY on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 7.61M shares
Security Ownership: 7.75%

Deerfield Management Company, L.P. ownership in ARS Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (SPRY)

2025-08-01 - Deerfield Management Company, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7.61M shares of ARS Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (SPRY). This represents 7.75% percent ownership of the company. In their previous filing dated 2025-07-22, Flynn James E had reported owning 8.63M shares, indicating a decrease of -11.9% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Deerfield Management Company, L.P.	7.75%	-11.6%	$101M	7.61M	-1,023,320	-11.9%	$13.29	13D/A	7/30/2025	1 Aug 2025 18:06:51
Deerfield Management Company, L.P.	8.79%	-11.1%	$115M	8.63M	-1,090,971	-11.2%	$13.29	13D/A	7/18/2025	22 Jul 2025 19:38:15
Deerfield Management Company, L.P.	9.9%	-7.45%	$129M	9.72M	-790,149	-7.51%	$13.29	13D/A	7/2/2025	2 Jul 2025 08:24:28
Deerfield Management Company, L.P.	10.72%		$148M	10.5M			$14.05	13D/A	3/20/2025	24 Mar 2025 19:57:55